Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-136055
Filing Date
2024-12-13
Accepted
2024-12-13 09:00:03
Documents
2
Period of Report
2024-12-11

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1539
2 EX-24 glue-ex24.htm EX-24 11823
  Complete submission text file 0000950170-24-136055.txt   14837
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Issuer) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TEVA 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Business Address
Hughes Eric A (Reporting) CIK: 0001938678 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40522 | Film No.: 241546924